Senior insider sale
CEO at BEAM THERAPEUTICS INC. — senior position signals high conviction
$3.05M
105.08K shares
What this filing means
EVANS JOHN M. plans to sell 105.08K shares of BEAM THERAPEUTICS INC. valued at approximately $3.05M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001950047-26-006639
DirectorOfficer· CEO
Since Feb 2020
105.08K
Shares to sell
$3.05M
Approx. market value
25K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/30/2026
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2026 | Stock Option Exercise Cash | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
25K
Market value
$887.4K
6/29/2026
—Completed
Units to sell
30.08K
Market value
$739.4K
4/1/2026
—Completed
Units to sell
25K
Market value
$569.1K
3/31/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
25K
Market value
$857.7K
6/30/2026
Total
Units
105.08K
Value
$3.05M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/29/2026 | 25K | $887.4K | — | Completed |
4/1/2026 | 30.08K | $739.4K | — | Completed |
3/31/2026 | 25K | $569.1K | — | Completed |
| Planned — Approximate Date | ||||
6/30/2026 | 25K | $857.7K | NASDAQ | Planned |
| Total | 105.08K | $3.05M | ||